K-Bro Linen Q2FY26 Results: Revenue up 33% YoY to CAD 150.4 million
- Revenue increased 33% YoY to CAD 150.4 million, driven by the Stellar acquisition and price increases
- Adjusted EBITDA rose 25.6% to CAD 29.8 million, with margins contracting 1.2% to 19.8%
- Healthcare revenue grew 50%, now comprising 58% of total revenue compared to 51% prior year
- Company achieved 40% of anticipated Stellar synergies, with full realization expected within 12 months
- Pro forma funded debt to EBITDA ratio remains under 2.5 times, supported by strong liquidity
*this image is generated using AI for illustrative purposes only.
K-Bro Linen Systems Incorporated (TSX: KBL) reported consolidated revenue of CAD 150.4 million for the second quarter of fiscal 2026, marking a 33% year-over-year increase. The growth was primarily driven by the acquisition of Stellar and implemented price increases, with healthcare revenue surging 50% to represent 58% of the total mix.
Adjusted EBITDA climbed 25.6% to CAD 29.8 million, though margins contracted 1.2% to 19.8% due to Stellar’s lower margin profile and elevated fuel costs. The company maintained a strong balance sheet, with a pro forma funded debt to EBITDA ratio under 2.5 times and significant undrawn credit capacity.
Segment Performance and Integration Progress
The acquisition of Stellar has reshaped K-Bro’s revenue composition, shifting the healthcare segment’s share from approximately 51% in the prior year to 58% in Q2FY26. Healthcare revenue grew 50% YoY, while hospitality revenue increased 15%. Geographically, the UK division accounted for 52.2% of consolidated revenue, slightly exceeding Canada’s 47.7% contribution.
Management reported that integration efforts for Stellar are progressing well, with 40% of anticipated synergies realized as of the end of Q2. The remaining synergies are expected to be captured over the next 12 months, with key initiatives including converting healthcare plants to seven-day working schedules and insourcing maintenance functions.
Margin Dynamics and Cost Pressures
While top-line growth was robust, profitability faced headwinds from operational costs. The consolidated adjusted EBITDA margin decreased to 19.8%, driven by the dilutive effect of Stellar’s margins and higher diesel prices. Management estimated that diesel rates negatively impacted Q2 adjusted EBITDA margins by half a percentage point.
In response to energy volatility, K-Bro has hedged 50% of its diesel usage in the UK, while Canadian usage remains floating. Despite these pressures, the Canadian division maintained a steady adjusted EBITDA margin of 21.1%, supported by route optimization and labor containment. The UK division saw its margin decline 2.1% to 18.6%, reflecting the combined impact of acquisition-related costs and fuel expenses.
Financial Position and Capital Allocation
K-Bro demonstrated disciplined capital allocation, distributing CAD 14.7 million in distributable cash flow with a payout ratio of 26.6%. The company paid dividends of CAD 0.30 per share and repurchased 58,000 common shares for CAD 2.5 million under its normal course issuer bid.
The balance sheet remains resilient, with total debt net of cash at CAD 213.5 million. To manage interest rate exposure, K-Bro entered into an interest rate swap in June to convert floating-rate term loan exposure to fixed rates. The company retains ample liquidity, including an undrawn operating line balance of nearly CAD 69.6 million and a CAD 50 million accordion facility for future growth.
What the Numbers Show
A divergence exists between revenue growth and margin expansion. While revenue expanded 33%, adjusted EBITDA grew only 25.6%, indicating that incremental revenue is coming at a lower margin than legacy operations. This is largely structural, stemming from Stellar’s acquisition which shifted the revenue mix toward healthcare (58% of total) but diluted overall margins by 1.2%. Additionally, the 40% synergy realization rate suggests that the full margin accretion from the acquisition has not yet been captured, leaving room for profitability improvement as integration completes over the next year.
How will the completion of the remaining 60% of Stellar synergies over the next 12 months specifically impact K-Bro's consolidated EBITDA margin trajectory?
What is the potential impact on UK division profitability if diesel prices remain elevated and the current 50% hedging coverage proves insufficient?
Does the shift to a healthcare-heavy revenue mix (58%) alter K-Bro's long-term risk profile regarding regulatory changes or hospital consolidation trends?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
